Try our Advanced Search for more refined results

Pfizer Should Face Lipitor Row In Calif., 3rd Circ. Hears

By Kat Greene (December 18, 2015, 7:47 PM EST) -- Pfizer Inc. and Ranbaxy Laboratories Inc. shouldn't have been able to kill a suit by nine pharmacists in multidistrict litigation over Lipitor because the pharmacists sued under California state law, not the federal standard that beat the suit, the pharmacists told the Third Circuit on Thursday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!